Transient Receptor Potential (TRP) Channels in Tumor Vascularization

Angelica Perna1, Carmine Sellitto2, Klara Komici1

  • 1Department of Medicine and Health Sciences "Vincenzo Tiberio", University of Molise, 86100 Campobasso, Italy.

Insights

Transient Receptor Potential (TRP) channels play a key role in tumor development. This review explores how endothelial TRP channels influence tumor angiogenesis, impacting cancer growth and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Physiology

Background:

  • Tumor progression involves complex cellular processes, including angiogenesis.
  • Ion channels, particularly Transient Receptor Potential (TRP) channels, are implicated in cancer development.
  • TRP channels regulate calcium (Ca2+) influx, a critical factor in cellular signaling.

Purpose of the Study:

  • To review the role of endothelial TRP channel isoforms in tumor angiogenesis.
  • To understand the contribution of TRP channels to tumor growth and metastasis.

Main Methods:

  • Literature review focusing on endothelial TRP channels and their function in cancer.
  • Analysis of studies investigating TRP channel involvement in neovascularization within tumors.

Main Results:

  • Specific endothelial TRP channel isoforms are crucial for tumor blood vessel formation.
  • Dysregulation of these channels can promote tumor growth and metastatic potential.

Conclusions:

  • Endothelial TRP channels represent potential therapeutic targets for anti-cancer strategies.
  • Targeting TRP channels could inhibit tumor angiogenesis, thereby limiting cancer progression.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.7K